Aerospace giant Lockheed Martin Corp (NYSE:LMT) is trading 3.8% higher at $544.81 this afternoon, maintaining its 12% year-to-date gain, but struggling to make any longer-term progress.
LMT clears a key PrSM Increment 4 propulsion test, aiming for 620 miles range and faster production via $300M manufacturing bets.
In the closing of the recent trading day, Lockheed Martin (LMT) stood at $519.05, denoting a +1.37% move from the preceding trading day.
Lockheed Martin's $186.4B backlog, new missile production facility and Aegis milestones support long-term revenue visibility despite program losses.
LMT's Aegis Combat System is gaining traction as global naval defense spending rises and allies expand missile defense readiness.
Lockheed (LMT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Lockheed Martin Corporation (LMT) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Both Boeing and Lockheed Martin benefit from significant exposure to military aircraft, space systems and government defense contracts.
Lockheed (LMT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The FY27 defense budget nearly doubles Research & Procurement spend, with F-35 up 62%, PAC-3/MSE up 8x, and THAAD up 9x—all core Lockheed Martin programs. LMT's backlog stands at $186.4B, with $63B recognizable in the next 12 months; the international sales mix is expanding to 31%. Margin headwinds from supply chain disruptions, tariffs, and rare earth shortages from the Strait of Hormuz closure.
LMT gains from a $186.4B backlog, F-35 demand and global defense deals, but program delays and high debt may keep new investors cautious.
Recently, Zacks.com users have been paying close attention to Lockheed (LMT). This makes it worthwhile to examine what the stock has in store.